Lys177

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Sumoylation Site Page: > Lys177 - WT1 (human)

Site Information
QFPNHSFkHEDPMGQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 2293712

In vivo Characterization
Methods used to characterize site in vivo:	modification-specific antibody ( 1 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:	bone cancer ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 1 ) , kidney ( 1 ) , U2OS (bone cell) ( 1 )

References
1	Smolen GA, et al. (2004) SUMO-1 modification of the Wilms' tumor suppressor WT1. Cancer Res 64, 7846-51 15520190 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.